Has Terry Box received payments from drug or device companies?

Yes. Drug and device makers reported $301,759 in general payments to Terry Box across 313 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Terry Box did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Terry Box come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Terry Box

Gastroenterology · Salt Lake City, UTNPI 1235142985

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $229,592 of the $301,759 with a category attached, or 76.1%. Gilead accounts for 63.7% of it on its own, with 8 other manufacturers making up the rest. Among gastroenterology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$301,759in general payments, 2019–2025

Across 313 payments — averaging $964.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$192K
Intercept Pharmaceuticals, Inc.$84K
AbbVie$20K
Mallinckrodt Hospital Products Inc.$5K
Eisai Inc.$187
Terumo Medical Corporation$147
plus $207 from 3 others

$500in research payments, 2019–2025

Across 1 payment — averaging $499.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intercept Pharmaceuticals, Inc.$500

What the payments were for

Consulting fees$27,0009%
Speaking & faculty fees$229,59276%
Travel & lodging$37,06912%
Food & beverage$8,0983%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	198	$192,239
Intercept Pharmaceuticals, Inc.	84	$84,224
AbbVie	24	$19,757
Mallinckrodt Hospital Products Inc.	1	$5,000
Eisai Inc.	2	$187
Terumo Medical Corporation	1	$147
Fujifilm Wako Diagnostics U.S.A. Corporation	1	$126
GSK	1	$57
Madrigal Pharmaceuticals	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Livdelzi$72,841
OCALIVA$62,982
Epclusa$52,450
Mavyret$19,230
Azur CX Detachable$293
Navicross$147
Wako HCC Biomarker(s) DCP and AFP-L3$126
LENVIMA$122
Vemlidy$122

How this compares

$301,759 in reported general payments places this provider in the 95th percentile of 122 gastroenterology providers in Utah.

See all gastroenterology providers in Utah →

Other gastroenterology in Salt Lake City

Richard GilroySalt Lake City$192K
Kathryn PetersonSalt Lake City$111K
John FangSalt Lake City$12K
Iqbal SandhuSalt Lake City$10K
John ValentineSalt Lake City$9K
Ann FlynnSalt Lake City$6K
Suryanarayana ChallaSalt Lake City$6K
Jason WillsSalt Lake City$6K
Chaya KrishnamurthySalt Lake City$5K
Ramon Minjares GranilloSalt Lake City$4K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →